Hyperfine (HYPR) Amortization of Deferred Charges (2026)

Hyperfine's (HYPR) quarterly Amortization of Deferred Charges came in at $17000.0 in Q1 2026.

Hyperfine (HYPR) Amortization of Deferred Charges (2026) Analysis & Trends

Hyperfine (HYPR) has 1 years of Amortization of Deferred Charges data on file, last reported at $17000.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.07 Bn	193.46 Bn	7.27 Bn
2	Stryker	127.90 Bn	124.43 Bn	4.50 Bn
3	Medtronic	118.84 Bn	109.62 Bn	6.41 Bn
4	Boston Scientific	73.33 Bn	72.79 Bn	3.85 Bn
5	Edwards Lifesciences	51.93 Bn	47.68 Bn	1.35 Bn
6	Dexcom	34.46 Bn	32.51 Bn	830.00 Mn
7	GE HealthCare Technologies	33.91 Bn	31.81 Bn	2.18 Bn
8	Koninklijke Philips	26.36 Bn	23.04 Bn	4.55 Bn
9	Steris	23.12 Bn	22.64 Bn	684.20 Mn
10	Hyperfine	89.22 Mn	44.45 Mn	1.98 Mn

Download Data